A severe course of COVID-19 displays dysregulated expression of checkpoint molecules, mainly PD-1 and its ligand PD-L1, as well as TIM-3, suggesting these checkpoint molecules could serve as prognostic markers and therapeutic targets in severe cases of COVID-19 [3]. This evidence concerns the gene CD274 and COVID-19.